We also observed that significantly different mutation frequencies in SLK, OTOP1, MYO1F, MYH3, FANCM, CSF2RA, ATP7A, and ANK3, while further studies were needed to explore their roles in glioma. Here, MYO1F is linked to central nervous system cancer.